The  European Respiratory Society (ERS) International Congress 2026  featured emerging insights across severe eosinophilic asthma, pediatric wheeze, allergic rhinitis, airway inflammation, and small airway dysfunction, including broader immunomodulatory effects of anti-IL-5/IL-5Rα therapies, early-life predictors of persistent wheeze and atopy, and immune signatures identified through plasma proteomics . 1–3 Other research explored the potential role of staphylococcal enterotoxin sensitisation in allergen immunotherapy, NLRP3/caspase-1-mediated epithelial pyroptosis, eosinophil-targeted CAR-T cells, CD84 regulation of ILC2 responses, and CPET-based assessment of disordered breathing .

4–8 Oscillometry findings also highlighted a high prevalence of small airway dysfunction among patients with rhinitis and sinusitis. 9 Explore this infographic to discover key research updates and emerging…